How "Compassionate" Are #Pharma Companies? Only 19% Says Study by Avalere | Pharmaguy's Insights Into Drug Industry News | Scoop.it

A new analysis from Avalere finds that only 19 percent of pharmaceutical and biotechnology companies publicly post their compassionate use policies on their web sites. Compassionate use is a process that enables patients to request access to investigational products outside of a clinical trial before the product is approved by the Food & Drug Administration. Current legislation being considered as part of the 21st Century Cures Act would require increased transparency.